USP is exploring how its extensive expertise in developing quality standards for drug products and ingredients can contribute to pharmaceutical continuous manufacturing.
You might also like...
// December 16, 2025
Nigeria’s drive to become an API manufacturing hub
Expanding production of active pharmaceutical ingredients (APIs) in Africa would increase the availability of essential medicines, reduce supply chain vulnerabilities, and improve health security and economic growth.
// May 23, 2025
A path to locally manufactured quality medicines: Building capacity in Africa to cond...
Bioequivalence (BE) studies are essential to assuring quality generic medicines. Yet Africa faces several challenges in conducting BE studies and increasing the demand for and availability of quality generics. Read the blog.
// December 19, 2024
Manufacturing pharmaceutical ingredients in Nigeria...
Poor-quality medical products are all too common in Africa, where substandard and falsified medicines kill nearly 500,000 people each year, according to the United Nations. The continent also has the highest prevalence of poor-quality medicines among low- and middle-income countries at 18.7 percent.
In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC), the national regulating authority for medical products, is prioritizing local production of medicines to ensure a safer supply of quality-assured medical products to protect patients and communities across the country and continent.